Here are the five most popular Becker's ASC Review gastroenterology and endoscopy stories for the week of March 14 to March 18.
GI & Endoscopy
EndoChoice CEO Mark Gilreath bought 20,000 shares of the company's stock, according to a South Florida Hedge Fund Managers report.
CMS plans to remove the value of moderate sedation from over 120 GI endoscopy codes, according to a report by the American Gastroenterological Association.
Fujifilm Medical Systems U.S.A. added a new high-resolution Double Balloon Endoscope to its Double Balloon Endoscopy technology portfolio.
Paul G. Fishbein, MD, and Vicente Lago, MD, joined Gastro Health in Miami.
Paul Lebovitz, MD, is a practicing gastroenterologist and system vice chair of integration at Allegheny Health Network in Pittsburgh. He is also an associate professor at Drexel University College of Medicine, also in Pittsburgh. He is board-certified in internal medicine…
Here are six gastroenterologists who recently made headlines.
A majority of physicians (64 percent) believe colon cancer screening guidelines should be changed to lower the recommended age of these screenings to younger than 50 years, according to a new survey by SERMO, a global social network for physicians…
Gastroenterologist Gregory D. Mackay, MD, has launched a campaign to represent District 54 in the Florida House, according to a TC Palm report.
Florida Hospital Physician Group in Tampa added Allen P. Chudzinski, MD, FACS, to its physician team.
